UniProt ID | S35B2_HUMAN | |
---|---|---|
UniProt AC | Q8TB61 | |
Protein Name | Adenosine 3'-phospho 5'-phosphosulfate transporter 1 | |
Gene Name | SLC35B2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 432 | |
Subcellular Localization |
Golgi apparatus membrane Multi-pass membrane protein . |
|
Protein Description | Mediates the transport of adenosine 3'-phospho 5'-phosphosulfate (PAPS), from cytosol into Golgi. PAPS is a universal sulfuryl donor for sulfation events that take place in the Golgi. May indirectly participate in activation of the NF-kappa-B and MAPK pathways.. | |
Protein Sequence | MDARWWAVVVLAAFPSLGAGGETPEAPPESWTQLWFFRFVVNAAGYASFMVPGYLLVQYFRRKNYLETGRGLCFPLVKACVFGNEPKASDEVPLAPRTEAAETTPMWQALKLLFCATGLQVSYLTWGVLQERVMTRSYGATATSPGERFTDSQFLVLMNRVLALIVAGLSCVLCKQPRHGAPMYRYSFASLSNVLSSWCQYEALKFVSFPTQVLAKASKVIPVMLMGKLVSRRSYEHWEYLTATLISIGVSMFLLSSGPEPRSSPATTLSGLILLAGYIAFDSFTSNWQDALFAYKMSSVQMMFGVNFFSCLFTVGSLLEQGALLEGTRFMGRHSEFAAHALLLSICSACGQLFIFYTIGQFGAAVFTIIMTLRQAFAILLSCLLYGHTVTVVGGLGVAVVFAALLLRVYARGRLKQRGKKAVPVESPVQKV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
14 | Ubiquitination | AVVVLAAFPSLGAGG HHHHHHHCCCCCCCC | 3.34 | 24816145 | |
29 | Ubiquitination | ETPEAPPESWTQLWF CCCCCCCCCHHHHHH | 58.82 | 33845483 | |
38 | Ubiquitination | WTQLWFFRFVVNAAG HHHHHHHHHHHHHHH | 17.61 | 33845483 | |
54 | Phosphorylation | ASFMVPGYLLVQYFR HHHHCCHHHHHHHHH | 7.27 | 18083107 | |
63 | Ubiquitination | LVQYFRRKNYLETGR HHHHHHHHCCCCCCC | 45.76 | 33845483 | |
73 | Ubiquitination | LETGRGLCFPLVKAC CCCCCCCHHHHHHHH | 3.53 | 32015554 | |
73 | S-palmitoylation | LETGRGLCFPLVKAC CCCCCCCHHHHHHHH | 3.53 | 29575903 | |
78 | Ubiquitination | GLCFPLVKACVFGNE CCHHHHHHHHHHCCC | 43.69 | 33845483 | |
80 | S-palmitoylation | CFPLVKACVFGNEPK HHHHHHHHHHCCCCC | 1.84 | 29575903 | |
82 | Ubiquitination | PLVKACVFGNEPKAS HHHHHHHHCCCCCCC | 9.76 | 33845483 | |
83 | Ubiquitination | LVKACVFGNEPKASD HHHHHHHCCCCCCCC | 19.73 | 29967540 | |
86 | Ubiquitination | ACVFGNEPKASDEVP HHHHCCCCCCCCCCC | 41.32 | 29967540 | |
87 | Ubiquitination | CVFGNEPKASDEVPL HHHCCCCCCCCCCCC | 55.11 | 33845483 | |
111 | Ubiquitination | TPMWQALKLLFCATG CHHHHHHHHHHHHHC | 46.27 | 29967540 | |
114 | Ubiquitination | WQALKLLFCATGLQV HHHHHHHHHHHCCHH | 3.74 | 29967540 | |
123 | Ubiquitination | ATGLQVSYLTWGVLQ HHCCHHHHHHHHHHH | 14.86 | 29967540 | |
126 | Ubiquitination | LQVSYLTWGVLQERV CHHHHHHHHHHHHHH | 7.72 | 29967540 | |
135 | Phosphorylation | VLQERVMTRSYGATA HHHHHHHHHCCCCCC | 17.38 | - | |
137 | Phosphorylation | QERVMTRSYGATATS HHHHHHHCCCCCCCC | 20.82 | 28152594 | |
138 | Phosphorylation | ERVMTRSYGATATSP HHHHHHCCCCCCCCC | 13.90 | 28152594 | |
167 | Ubiquitination | RVLALIVAGLSCVLC HHHHHHHHHHHHHHC | 13.25 | 29967540 | |
170 | Ubiquitination | ALIVAGLSCVLCKQP HHHHHHHHHHHCCCC | 10.97 | 29967540 | |
208 | Phosphorylation | YEALKFVSFPTQVLA HHHHHHCCCCHHHHH | 28.74 | - | |
211 | Ubiquitination | LKFVSFPTQVLAKAS HHHCCCCHHHHHHHH | 29.33 | 29967540 | |
214 | Ubiquitination | VSFPTQVLAKASKVI CCCCHHHHHHHHCHH | 2.66 | 29967540 | |
216 | Acetylation | FPTQVLAKASKVIPV CCHHHHHHHHCHHHH | 49.37 | 26051181 | |
216 | Ubiquitination | FPTQVLAKASKVIPV CCHHHHHHHHCHHHH | 49.37 | 29967540 | |
218 | Phosphorylation | TQVLAKASKVIPVML HHHHHHHHCHHHHHH | 27.09 | 20068231 | |
219 | Malonylation | QVLAKASKVIPVMLM HHHHHHHCHHHHHHC | 49.39 | 26320211 | |
219 | Ubiquitination | QVLAKASKVIPVMLM HHHHHHHCHHHHHHC | 49.39 | 29967540 | |
283 | Ubiquitination | AGYIAFDSFTSNWQD HHHHHHHHCCCCHHH | 24.78 | 23503661 | |
287 | Ubiquitination | AFDSFTSNWQDALFA HHHHCCCCHHHHHHH | 37.05 | 33845483 | |
288 | Ubiquitination | FDSFTSNWQDALFAY HHHCCCCHHHHHHHH | 9.37 | 33845483 | |
288 | Ubiquitination | FDSFTSNWQDALFAY HHHCCCCHHHHHHHH | 9.37 | - | |
294 | Phosphorylation | NWQDALFAYKMSSVQ CHHHHHHHHHHHHHH | 12.14 | 32142685 | |
298 | Ubiquitination | ALFAYKMSSVQMMFG HHHHHHHHHHHHHHC | 24.17 | 33845483 | |
298 | Ubiquitination | ALFAYKMSSVQMMFG HHHHHHHHHHHHHHC | 24.17 | - | |
311 | Ubiquitination | FGVNFFSCLFTVGSL HCCCHHHHHHHHHHH | 2.83 | 23503661 | |
315 | Ubiquitination | FFSCLFTVGSLLEQG HHHHHHHHHHHHHHC | 3.72 | 33845483 | |
316 | Ubiquitination | FSCLFTVGSLLEQGA HHHHHHHHHHHHHCC | 14.98 | 33845483 | |
322 | Phosphorylation | VGSLLEQGALLEGTR HHHHHHHCCCHHCCC | 14.60 | 32142685 | |
323 | Ubiquitination | GSLLEQGALLEGTRF HHHHHHCCCHHCCCC | 14.52 | 23503661 | |
326 | Ubiquitination | LEQGALLEGTRFMGR HHHCCCHHCCCCCCC | 60.41 | 33845483 | |
327 | Ubiquitination | EQGALLEGTRFMGRH HHCCCHHCCCCCCCC | 23.35 | 33845483 | |
328 | Ubiquitination | QGALLEGTRFMGRHS HCCCHHCCCCCCCCH | 16.03 | 33845483 | |
334 | Phosphorylation | GTRFMGRHSEFAAHA CCCCCCCCHHHHHHH | 26.42 | 32142685 | |
338 | Ubiquitination | MGRHSEFAAHALLLS CCCCHHHHHHHHHHH | 8.35 | 33845483 | |
367 | Ubiquitination | GQFGAAVFTIIMTLR HHHHHHHHHHHHHHH | 3.30 | 23503661 | |
371 | Ubiquitination | AAVFTIIMTLRQAFA HHHHHHHHHHHHHHH | 2.26 | 33845483 | |
372 | Ubiquitination | AVFTIIMTLRQAFAI HHHHHHHHHHHHHHH | 14.37 | 33845483 | |
378 | Phosphorylation | MTLRQAFAILLSCLL HHHHHHHHHHHHHHH | 8.44 | 32142685 | |
381 (in isoform 2) | Ubiquitination | - | 2.51 | - | |
382 | Ubiquitination | QAFAILLSCLLYGHT HHHHHHHHHHHHCCC | 10.16 | 33845483 | |
389 | Phosphorylation | SCLLYGHTVTVVGGL HHHHHCCCCEEECCH | 17.32 | 19369195 | |
391 (in isoform 2) | Ubiquitination | - | 15.61 | - | |
411 | Ubiquitination | ALLLRVYARGRLKQR HHHHHHHHHHHHHHC | 12.47 | 23503661 | |
415 | Ubiquitination | RVYARGRLKQRGKKA HHHHHHHHHHCCCCC | 6.54 | 33845483 | |
416 | Ubiquitination | VYARGRLKQRGKKAV HHHHHHHHHCCCCCC | 36.27 | 33845483 | |
420 | Ubiquitination | GRLKQRGKKAVPVES HHHHHCCCCCCCCCC | 39.48 | 33845483 | |
421 | Ubiquitination | RLKQRGKKAVPVESP HHHHCCCCCCCCCCC | 58.39 | 33845483 | |
422 | Phosphorylation | LKQRGKKAVPVESPV HHHCCCCCCCCCCCC | 17.84 | 32142685 | |
426 | Ubiquitination | GKKAVPVESPVQKV- CCCCCCCCCCCCCC- | 43.16 | 33845483 | |
427 | Phosphorylation | KKAVPVESPVQKV-- CCCCCCCCCCCCC-- | 30.52 | 29255136 | |
431 | Ubiquitination | PVESPVQKV------ CCCCCCCCC------ | 50.58 | 33845483 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of S35B2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of S35B2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of S35B2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of S35B2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-427, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-427, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-427, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-427, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-427, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-427, AND MASSSPECTROMETRY. |